^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

FT819

i
Other names: FT819, iPSC-derived CAR T-Cell Cancer Immunotherapy, TCR-less, TRAC-Targeted CAR19 iT, CAR19 TCR-null T-Cell therapy
Associations
Company:
Fate Therap, Memorial Sloan-Kettering Cancer Center
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations